Fractyl Health (GUTS) Operating Expenses (2023 - 2026)
Fractyl Health (GUTS) reported Operating Expenses of $20.8 million for Q1 2026, down 15.91% year-on-year from $24.8 million in Q1 2025, and down 10.58% quarter-over-quarter from $23.3 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Operating Expenses data on file, last reported at $20.8 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses fell 15.91% year-over-year to $20.8 million; the trailing twelve-month figure through Mar 2026 stood at $92.9 million (down 4.03% YoY), and the FY2025 full-year result was $96.8 million, up 3.46% from the prior year.
- Operating Expenses for Q1 2026 stood at $20.8 million, down from $23.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $26.1 million in Q2 2025 and bottomed at $11.9 million in Q2 2023.
- A 4-year average of $20.2 million and a median of $22.7 million in 2025 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses soared 94.16% in 2024 and fell 15.91% in 2026, its largest moves.
- Tracing GUTS's Operating Expenses over 4 years: stood at $13.0 million in 2023, then soared by 94.16% to $25.2 million in 2024, then decreased by 7.65% to $23.3 million in 2025, then decreased by 10.58% to $20.8 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $20.8 million, $23.3 million, and $22.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -3.82 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 20.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.82 Mn |
| Dec 31, 2025 | 23.28 Mn |
| Sep 30, 2025 | 22.69 Mn |
| Jun 30, 2025 | 26.08 Mn |
| Mar 31, 2025 | 24.76 Mn |
| Dec 31, 2024 | 25.21 Mn |
| Sep 30, 2024 | 23.80 Mn |
| Jun 30, 2024 | 23.00 Mn |
| Mar 31, 2024 | 21.56 Mn |
| Dec 31, 2023 | 12.99 Mn |
| Sep 30, 2023 | 13.88 Mn |
| Jun 30, 2023 | 11.90 Mn |
| Mar 31, 2023 | 12.11 Mn |